Gotham Therapeutics

Gotham Therapeutics has assembled a specialized team to establish a new class of drugs targeting RNA-modifying proteins. By modulating the activity of proteins that modify messenger RNA, our goal is to develop novel therapeutic options for patients suffering from cancer, autoimmune diseases, and neurodegenerative disorders. We are applying a 360-degree approach to small molecule drug design in order to build a pipeline based on the promising prospects of this rapidly emerging biopharmaceutical field.